Why is this new/important: Jardiance is currently approved in the US for type 2 diabetes, but not type 1
The outcomes for this secondary mechanistic analysis from SUMMIT were identified on the basis of pathophysiologic understanding of obesity-related HFpEF as variables that we hypothesized would change with tirzepatide treatment, including measures of BP, estimated BV and PV, kidney function, albuminuria, cardiac injury, inflammation and cardiac distention (reflected by NT-proBNP)
Existing Licensed Alternatives Available on the NHS Licensed weight management medicines currently available in the UK include semaglutide (Wegovy), tirzepatide (Mounjaro), orlistat, liraglutide (Saxenda), and naltrexone/bupropion (Mysimba), subject to eligibility criteria
Selenium supplementation and secondary prevention of nonmelanoma skin cancer in a randomized trial
However, as we will discuss when we talk about charging, it is generally a good idea to charge at a rate of 1C, 1.5C maximum
Both drugs conferred an improvement in physical component summary score at 72 weeks from baseline among the limited physical function subgroup